DRTS (DRTS) Stock Price & Analysis
DRTS (DRTS) fell 1.26% to USD 14.84 as of September 9, 2026 at 13:23 UTC, according to Nexqual real-time market data.
DRTS last closed at USD 14.84; the session ranged USD 14.47–15.08 on volume of 561,445 shares. Market capitalization is —, with a 52-week range of USD 3.43–15.17 (NCM). Source: Nexqual, September 9, 2026 at 13:23 UTC.
Key Statistics (as of September 9, 2026 at 13:23 UTC)
| Price | USD 14.84 |
|---|---|
| Change | ▼ 1.26% (down) |
| Previous Close | USD 14.84 |
| Open | USD 14.84 |
| Day Range | USD 14.47 – 15.08 |
| 52-Week Range | USD 3.43 – 15.17 |
| Volume | 561,445 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DRTS)
Nexqual's technical model rates DRTS "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 13:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.99 (neutral) |
| vs SMA50 | Above (USD 13.38) |
| MACD | 0.45 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc | USD 13.96 | ▲ 1.9% |
| HOVR | New Horizon Aircraft Ltd. | USD 1.66 | ▼ 0.6% |
| GANX | Gain Therapeutics, Inc. | USD 1.83 | ▲ 0.55% |
| NRSN | NeuroSense Therapeutics Ltd. | USD 0.42 | ▲ 4% |
| NVCT | Nuvectis Pharma, Inc. | USD 23.99 | ▼ 1.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:23 UTC. This page is informational and not investment advice.